XBiotech (STU:4XB) General and Admin. Expense: €6.37 Mil (TTM As of Mar. 2026)


STU:4XB XBiotech Inc STU:4XB
38 GF Score
Price €2.00
GF Value €0.15
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is XBiotech General and Admin. Expense?

XBiotech STU:4XB 38 General and Admin. Expense is €6.37 Mil as of Mar. 2026. GuruFocus rates STU:4XB with a GF Score™ of 38/100 and a GF Value™ of €0.15 (Significantly Overvalued). The stock has 2 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. XBiotech's General and Admin. Expense for the three months ended in Mar. 2026 was €0.92 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €6.37 Mil.

XBiotech General and Admin. Expense Related Terms

XBiotech General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for XBiotech's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XBiotech General and Admin. Expense Chart

XBiotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.31 5.95 4.28 4.50 7.08

XBiotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.79 0.87 0.82 3.76 0.92
STU:4XB
38GF Score
XBiotech Inc STU:4XB
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XBiotech General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of €6.37 Mil mean?
XBiotech (STU:4XB) has a General and Admin. Expense of €6.37 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on XBiotech and its competitors.
Is XBiotech's General and Admin. Expense too high?
XBiotech's current General and Admin. Expense is €6.37 Mil. Overall, XBiotech has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does XBiotech's General and Admin. Expense compare to ACRV and EXOZ?
XBiotech's General and Admin. Expense of €6.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on XBiotech and its competitors. XBiotech's current General and Admin. Expense is €6.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XBiotech stock overvalued right now?
Based on GuruFocus' analysis, XBiotech (STU:4XB) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.15, compared to a current price of €2.00 — trading 1233.3% above its estimated fair value. The current General and Admin. Expense is €6.37 Mil. XBiotech's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For XBiotech (STU:4XB), the current General and Admin. Expense is €6.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XBiotech (STU:4XB) Overvalued in 2026?

Based on GuruFocus' analysis, XBiotech stock appears to be overvalued. The current stock price of €2.00 is trading 1233.3% above its estimated GF Value™ of €0.15. GuruFocus considers XBiotech to be Significantly Overvalued.

Key valuation signals for STU:4XB:

  • General and Admin. Expense: €6.37 Mil
  • GF Value™: €0.15 vs. price of €2.00 (1233.3% above fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the STU:4XB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XBiotech Business Description

Other Exchanges XBIT:USA
Address 5217 Winnebago Lane, Austin, TX, USA, 78744
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
38GF Score

Get the complete analysis for STU:4XB

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.00
Price
€0.15
GF Value